VERU INC. Increase (Decrease) in Derivative Assets and Liabilities
VERU INC. (VERU) reported Increase (Decrease) in Derivative Assets and Liabilities of $19.00 thousand for the 6-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeAssetsAndLiabilities · last filed 2024-05-08
- VERU INC. increase (decrease) in derivative assets and liabilities for the quarter ending 2024-03-31 was $21.00K, a 98.25% decline year-over-year.
- VERU INC. increase (decrease) in derivative assets and liabilities for the quarter ending 2023-12-31 was -$2.00K.
- VERU INC. increase (decrease) in derivative assets and liabilities for the quarter ending 2023-09-30 was $644.00K, a 84.35% decline year-over-year.
- VERU INC. increase (decrease) in derivative assets and liabilities for the quarter ending 2023-06-30 was $1.79M, a 103.06% increase year-over-year.
- VERU INC. increase (decrease) in derivative assets and liabilities for fiscal 2023 was $2.96M, a 16.70% decline from fiscal 2022.
- VERU INC. increase (decrease) in derivative assets and liabilities for fiscal 2022 was $3.56M.
- VERU INC. increase (decrease) in derivative assets and liabilities for fiscal 2021 was -$3.67M.
- VERU INC. increase (decrease) in derivative assets and liabilities for fiscal 2020 was -$557.00K.
| Period end | Increase (Decrease) in Derivative Assets and Liabilities 3 month | Increase (Decrease) in Derivative Assets and Liabilities 6 month | Increase (Decrease) in Derivative Assets and Liabilities 9 month | Increase (Decrease) in Derivative Assets and Liabilities 12 month |
|---|---|---|---|---|
| 2024-03-31 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $19.00K 10-Q · filed 2024-05-08 | $663.00K derived: sum of 3 quarters · filed 2024-05-08 | $2.45M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | -$2.00K 10-Q · filed 2024-04-01 | $642.00K derived: sum of 2 quarters · filed 2024-04-01 | $2.43M derived: sum of 3 quarters · filed 2024-04-01 | $3.63M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-09-30 | $644.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $2.43M derived: sum of 2 quarters · filed 2024-04-01 | $3.63M derived: sum of 3 quarters · filed 2024-05-08 | $2.96M 10-K/A · filed 2024-04-01 |
| 2023-06-30 | $1.79M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-11-15 | $2.99M derived: sum of 2 quarters · filed 2024-05-08 | $2.32M 10-Q/A · filed 2023-11-15 | $6.43M derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-03-31 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $530.00K 10-Q · filed 2024-05-08 | $4.64M derived: sum of 3 quarters · filed 2024-05-08 | $5.53M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | -$670.00K 10-Q · filed 2024-04-01 | $3.44M derived: sum of 2 quarters · filed 2024-04-01 | $4.33M derived: sum of 3 quarters · filed 2024-04-01 | $3.10M derived: sum of 4 quarters · filed 2024-04-01 |
| 2022-09-30 | $4.11M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2024-04-01 | $5.00M derived: sum of 2 quarters · filed 2024-04-01 | $3.77M derived: sum of 3 quarters · filed 2024-04-01 | $3.56M 10-K/A · filed 2024-04-01 |
| 2022-06-30 | $881.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2023-11-15 | -$348.00K derived: sum of 2 quarters · filed 2023-11-15 | -$557.00K 10-Q/A · filed 2023-11-15 | -$2.20M derived: sum of 4 quarters · filed 2023-11-15 |
| 2022-03-31 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | -$1.44M 10-Q · filed 2023-05-11 | -$3.08M derived: sum of 3 quarters · filed 2023-05-11 | -$4.45M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$209.00K 10-Q · filed 2023-02-09 | -$1.85M derived: sum of 2 quarters · filed 2023-02-09 | -$3.22M derived: sum of 3 quarters · filed 2023-02-09 | -$3.27M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-05 | -$3.01M derived: sum of 2 quarters · filed 2022-12-05 | -$3.06M derived: sum of 3 quarters · filed 2022-12-05 | -$3.67M 10-K · filed 2022-12-05 |
| 2021-06-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | -$1.43M derived: sum of 2 quarters · filed 2022-08-11 | -$2.03M 10-Q · filed 2022-08-11 | -$2.49M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$657.00K 10-Q · filed 2022-05-12 | -$1.12M derived: sum of 3 quarters · filed 2022-05-12 | -$1.29M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$604.00K 10-Q · filed 2022-02-09 | -$1.07M derived: sum of 2 quarters · filed 2022-02-09 | -$1.24M derived: sum of 3 quarters · filed 2022-02-09 | -$767.00K derived: sum of 4 quarters · filed 2022-02-09 |
| 2020-09-30 | -$463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-02 | -$632.00K derived: sum of 2 quarters · filed 2021-12-02 | -$163.00K derived: sum of 3 quarters · filed 2021-12-02 | -$557.00K 10-K · filed 2021-12-02 |
| 2020-06-30 | -$169.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | $300.00K derived: sum of 2 quarters · filed 2021-08-12 | -$94.00K 10-Q · filed 2021-08-12 | -$1.05M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $469.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-12 | $75.00K 10-Q · filed 2021-05-12 | -$878.00K derived: sum of 3 quarters · filed 2021-05-12 | -$721.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | -$394.00K 10-Q · filed 2021-02-10 | -$1.35M derived: sum of 2 quarters · filed 2021-02-10 | -$1.19M derived: sum of 3 quarters · filed 2021-02-10 | -$1.82M derived: sum of 4 quarters · filed 2021-02-10 |
| 2019-09-30 | -$953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-10 | -$796.00K derived: sum of 2 quarters · filed 2020-12-10 | -$1.42M derived: sum of 3 quarters · filed 2020-12-10 | -$1.20M 10-K · filed 2020-12-10 |
| 2019-06-30 | $157.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-13 | -$471.00K derived: sum of 2 quarters · filed 2020-08-13 | -$246.00K 10-Q · filed 2020-08-13 | $1.05M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$628.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-13 | -$403.00K 10-Q · filed 2020-05-13 | $889.00K derived: sum of 3 quarters · filed 2020-05-13 | $511.00K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $225.00K 10-Q · filed 2020-02-12 | $1.52M derived: sum of 2 quarters · filed 2020-02-12 | $1.14M derived: sum of 3 quarters · filed 2020-02-12 | |
| 2018-09-30 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-12 | $914.00K derived: sum of 2 quarters · filed 2019-12-12 | $893.00K 10-K · filed 2019-12-12 | |
| 2018-06-30 | -$378.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-08 | -$399.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | -$21.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |